These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1111 related items for PubMed ID: 17258503

  • 1. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M, Dillner J.
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [Abstract] [Full Text] [Related]

  • 2. Correlating immunity with protection for HPV infection.
    Frazer I.
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Nov; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 5. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

  • 6. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
    Villa LL.
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241
    [Abstract] [Full Text] [Related]

  • 7. Cervical cancer vaccination indications, efficacy, and side effects.
    Bayas JM, Costas L, Muñoz A.
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S11-4. PubMed ID: 18586311
    [Abstract] [Full Text] [Related]

  • 8. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 9. [HPV vaccination: principles, results and future perspectives].
    Rouzier R, Uzan C, Collinet P.
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb 01; 36(1):13-8. PubMed ID: 17293248
    [Abstract] [Full Text] [Related]

  • 10. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M.
    Gynecol Oncol; 2007 Nov 01; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [Abstract] [Full Text] [Related]

  • 11. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
    Society of Gynecologic Oncologists Education Resource Panel Writing groupUniversity of Illinois, Chicago, IL, USA., Collins Y, Einstein MH, Gostout BS, Herzog TJ, Massad LS, Rader JS, Wright J.
    Gynecol Oncol; 2006 Sep 01; 102(3):552-62. PubMed ID: 16979432
    [Abstract] [Full Text] [Related]

  • 12. [Human papillomavirus vaccines].
    Brun JL.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb 01; 37 Suppl 1():S155-66. PubMed ID: 18187268
    [Abstract] [Full Text] [Related]

  • 13. Cervical cancer prevention in the human papilloma virus vaccine era.
    Ghazal-Aswad S.
    Ann N Y Acad Sci; 2008 Sep 01; 1138():253-6. PubMed ID: 18837904
    [Abstract] [Full Text] [Related]

  • 14. [Human papillomavirus vaccination. Consensus Conference in pediatric age].
    Bartolozzi G, Bona G, Ciofi M, De Martino M, Di Pietro P, Duse M, Esposito S, Gasparini R, Mariani L, Marostica G, Paravati F, Plebani A, Principi N, Zuccotti GV, Tovo PA.
    Minerva Pediatr; 2007 Jun 01; 59(3):165-82. PubMed ID: 17519861
    [Abstract] [Full Text] [Related]

  • 15. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M, Jasani B, Fiander A.
    Vaccine; 2007 Apr 20; 25(16):3007-13. PubMed ID: 17292517
    [Abstract] [Full Text] [Related]

  • 16. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.
    Pharmacotherapy; 2011 Mar 20; 31(3):280-97. PubMed ID: 21361739
    [Abstract] [Full Text] [Related]

  • 17. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
    Bornstein J, Tuma R, Zarfati D, Ophir E.
    Harefuah; 2007 Oct 20; 146(10):764-9, 814. PubMed ID: 17990391
    [Abstract] [Full Text] [Related]

  • 18. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2007 Mar 23; 56(RR-2):1-24. PubMed ID: 17380109
    [Abstract] [Full Text] [Related]

  • 19. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.
    Schwarz TF.
    Adv Ther; 2009 Nov 23; 26(11):983-98. PubMed ID: 20024678
    [Abstract] [Full Text] [Related]

  • 20. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
    Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Sings HL, James M, Hesley TM, Barr E.
    J Infect Dis; 2009 Apr 01; 199(7):926-35. PubMed ID: 19236279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.